Epitomee Medical raises $8m for novel weight-loss device

Early-stage medical device developer Epitomee Medical said today that it raised $8 million in a new round of equity financing to support its novel Epitomee Capsule “shapeshifting” pill intended to prevent diabetes and promote weight loss. The Israel-based company said that its Epitomee Capsule contains a shape-shifting scaffold that, after it is ingested, helps the body have an early sensation of fullness and prolonged gastric emptying through direct mechanosensory stimulation. The pills are designed to be taken twice a day to lower caloric intake and promote weight loss, Epitomee Medical said. “The Epitomee solution is  a novel practical approach in the fight against the global obesity epidemic. The combination of a simple, self-administered capsule and a high degree of safety and effectiveness makes it an optimal solution to this epidemic. The new partnership and this financing provide Epitomee with the resources to complete its next phase clinical trial  and reach a significant  value inflection point,” co-founder & chair Dr. Shimon Eckhouse said in a prepared statement. Data from an initial clinical study of the capsule indicated that the device met its endpoints and showed weight loss and glycemic control improvement, as well as ameliorated blood pressure levels and no safety concerns within 12 weeks of treatment. “The Epitomee Capsule has the potential to be the first-line, drug-free treatment for overweight, prediabetic, and modera...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Diabetes Wall Street Beat Weight loss epitomeemedical Source Type: news